{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:35:55Z","timestamp":1777415755514,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[1982,3,1]],"date-time":"1982-03-01T00:00:00Z","timestamp":383788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"published-print":{"date-parts":[[1982,3]]},"abstract":"<jats:p>The treatment of various cardiovascular problems with intravenous nitroglycerin is widely practiced though unapproved. The uses of iv nitroglycerin include improvement of the hemodynamics of left ventricular failure and cardiogenic shock associated with infarction, control of hypertension during coronary artery surgery, and possibly, reduction of acute myocardial infarct size. The popularity of this treatment in the absence of an FDA-approved commercial product has forced some hospitals to prepare the drug extemporaneously, and the advantages and disadvantages of preparation and storage techniques are presented.<\/jats:p>","DOI":"10.1177\/106002808201600304","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T02:03:11Z","timestamp":1498874591000},"page":"211-217","source":"Crossref","is-referenced-by-count":4,"title":["Nitroglycerin Intravenous Infusion"],"prefix":"10.1177","volume":"16","author":[{"given":"Gary T.","family":"Elliott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1982,3]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.51.1.132"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197607000-00004"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)28302-1"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.22.5.649"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1979.tb13669.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)28774-2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104352"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.6.1118"},{"key":"e_1_2_1_10_2","first-page":"540","article-title":"Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease","volume":"40","author":"Miler RR","year":"1977","unstructured":"Miler RR, Awan NA, DeMaria AW, Amsterdam EA, Mason DT. Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Am J Cardiol 1977; 40: 540\u20138.","journal-title":"Am J Cardiol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365516909078085"},{"key":"e_1_2_1_12_2","first-page":"496","volume-title":"The Merck manual","author":"Windholz M","year":"1976","unstructured":"Windholz M, ed. The Merck manual, 13th ed. Rahway, NJ: Merck and Co., 1976: 496\u20137.","edition":"13"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.32.6.728"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197107152850301"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.46.5.839"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.47.1.51"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.49.2.291"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.43.1.67"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.54.5.766"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.38.6.612"},{"key":"e_1_2_1_21_2","first-page":"4","article-title":"Hemodynamic effects of nitroprusside infusion during coronary artery operation in man","volume":"54","author":"Zappas DG","year":"1976","unstructured":"Zappas DG, Zowenstein E, Waller J, Fahmy NR, Daggett WM. Hemodynamic effects of nitroprusside infusion during coronary artery operation in man. Circulation 1976; 54 (suppl 3): 4\u201310.","journal-title":"Circulation"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108777"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.57.4.732"},{"key":"e_1_2_1_24_2","first-page":"73","article-title":"Electrocardiographic ST segment analysis in the characterization of acute myocardial ischemia and infarction","volume":"53","author":"Ross J","year":"1976","unstructured":"Ross JJr. Electrocardiographic ST segment analysis in the characterization of acute myocardial ischemia and infarction. Circulation 1976; 53 (suppl 1): 73\u201381.","journal-title":"Circulation"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(75)90888-7"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.60.1.121"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-4-435"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)40974-4"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90669-9"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197501022920107"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31715-1"},{"key":"e_1_2_1_32_2","first-page":"201","article-title":"Nitroglycerin compatibility with intravenous fluid filters, containers and administration sets","volume":"37","author":"Baaske DM","year":"1980","unstructured":"Baaske DM, Amann AH, Wagenknecht DM, , Nitroglycerin compatibility with intravenous fluid filters, containers and administration sets. Am J Hosp Pharm 1980; 37: 201\u201310.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92945-8"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1980.tb12905.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197612092952406"},{"key":"e_1_2_1_36_2","first-page":"1551","volume-title":"Harrison's principles of internal medicine","author":"Isselbacher KJ","year":"1980","unstructured":"Isselbacher KJ, ed. Harrison's principles of internal medicine, 9th ed. New York: McGraw Hill, 1980: 1551\u20132.","edition":"9"},{"key":"e_1_2_1_37_2","first-page":"302","volume-title":"Interpretation of diagnostic tests","author":"Wallach J","year":"1978","unstructured":"Wallach J. Interpretation of diagnostic tests, 3rd ed. Boston: Little, Brown, 1978: 302\u20133.","edition":"3"},{"key":"e_1_2_1_38_2","first-page":"173","article-title":"Potency and stability of extemporaneous nitroglycerin infusions","volume":"36","author":"McNiff B","year":"1979","unstructured":"McNiff B, McNiff EF, Fung H. Potency and stability of extemporaneous nitroglycerin infusions. Am J Hosp Pharm 1979; 36: 173\u20137.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_39_2","first-page":"537","article-title":"Stability of nitroglycerin injection determined by gas Chromatograph","volume":"35","author":"Sturek J","year":"1978","unstructured":"Sturek J, Sokoloski T, Winsley W, Stach P. Stability of nitroglycerin injection determined by gas Chromatograph. Am J Hosp Pharm 1978; 35: 537\u201341.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002807901300103"},{"key":"e_1_2_1_41_2","first-page":"858","volume-title":"The Merck index","author":"Windholz M","year":"1976","unstructured":"Windholz M, ed. The Merck index, 9th ed. Rahway, NJ: Merck and Co., 1976: 858\u20139.","edition":"9"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.1.160"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(78)90170-9"},{"key":"e_1_2_1_44_2","first-page":"1036","article-title":"Preparation and standardization of nitroglycerin injection","volume":"52","author":"Dean TW","year":"1975","unstructured":"Dean TW, Baun DC. Preparation and standardization of nitroglycerin injection. Am J Hosp Pharm 1975; 52: 1036\u20138.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_45_2","first-page":"541","article-title":"Apparent stability of nitroglycerin in dextrose 5% in water","volume":"35","author":"Ludwig D","year":"1978","unstructured":"Ludwig D, Veda C. Apparent stability of nitroglycerin in dextrose 5% in water. Am J Hosp Pharm 1978; 35: 541\u20134.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_46_2","first-page":"1031","article-title":"Stability of nitroglycerin solutions in Viaflex\u00ae plastic containers","volume":"35","author":"Boylan J","year":"1978","unstructured":"Boylan J, Robinson R, Terill P. Stability of nitroglycerin solutions in Viaflex\u00ae plastic containers. Am J Hosp Pharm 1978; 35: 1031.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_47_2","first-page":"261","volume":"32","year":"1975","unstructured":"National Coordinating Committee on Large Volume Parenterals. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm 1975; 32: 261\u201370.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_48_2","first-page":"122","article-title":"Principles and applications of the Limulus Test for pyrogen in parenteral drugs","volume":"29","author":"Cooper JF","year":"1975","unstructured":"Cooper JF. Principles and applications of the Limulus Test for pyrogen in parenteral drugs. Bull Parenter Drug Assoc 1975; 29: 122\u201330.","journal-title":"Bull Parenter Drug Assoc"},{"key":"e_1_2_1_49_2","first-page":"674","volume-title":"United States pharmacopeia","author":"United States Pharmacopeial Convention.","year":"1975","unstructured":"United States Pharmacopeial Convention. United States pharmacopeia, 19th ed. Easton: Mack Printing Company, 1975:343, 674.","edition":"19"}],"container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808201600304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808201600304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:00:40Z","timestamp":1777374040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002808201600304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,3]]}},"alternative-id":["10.1177\/106002808201600304"],"URL":"https:\/\/doi.org\/10.1177\/106002808201600304","relation":{},"ISSN":["0012-6578"],"issn-type":[{"value":"0012-6578","type":"print"}],"subject":[],"published":{"date-parts":[[1982,3]]}}}